Biogen Archives - Express Pharma

Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease

USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment

FDA accepts NDA and grants priority review of Zuranolone from Sage Therapeutics, Biogen

Eisai files for approval of Alzheimer’s drug in Japan

Eisai files for approval of Alzheimer’s drug in Europe

Roche’s Alzheimer’s drug fails to meet goal in long awaited trial

Biogen raises annual profit forecast for second straight quarter

US health regulator extends review of Biogen’s ALS drug

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Schneider Electric launches programme to increase access to renewable energy for pharmaceutical suppliers